Gemei M - Search Results

1

"Molecular Anatomy": a new multi-dimensional hierarchical scaffold analysis tool.

Manelfi C, Gemei M, Talarico C, Cerchia C, Fava A, Lunghini F, Beccari AR. Manelfi C, et al. Among authors: gemei m. J Cheminform. 2021 Jul 23;13:54. doi: 10.1186/s13321-021-00526-y. eCollection 2021. J Cheminform. 2021. PMID: 34301327 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 34316299

3

Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.

Gemei M, Talarico C, Brandolini L, Manelfi C, Za L, Bovolenta S, Liberati C, Vecchio LD, Russo R, Cerchia C, Allegretti M, Beccari AR. Gemei M, et al. Int J Mol Sci. 2020 Oct 16;21(20):7677. doi: 10.3390/ijms21207677. Int J Mol Sci. 2020. PMID: 33081372 Free PMC article.

4

ADPredict: ADP-ribosylation site prediction based on physicochemical and structural descriptors.

Lo Monte M, Manelfi C, Gemei M, Corda D, Beccari AR. Lo Monte M, et al. Among authors: gemei m. Bioinformatics. 2018 Aug 1;34(15):2566-2574. doi: 10.1093/bioinformatics/bty159. Bioinformatics. 2018. PMID: 29554239 Free PMC article.

5

Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.

Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: gemei m. Sci Rep. 2017 Sep 8;7(1):10999. doi: 10.1038/s41598-017-11194-0. Sci Rep. 2017. PMID: 28887460 Free PMC article.

6

Publisher Correction: Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.

Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: gemei m. Sci Rep. 2018 Mar 6;8(1):4250. doi: 10.1038/s41598-018-21902-z. Sci Rep. 2018. PMID: 29511237 Free PMC article.

7

Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.

Corbo C, Orrù S, Gemei M, Noto RD, Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD, Salvatore F. Corbo C, et al. Among authors: gemei m. Proteomics. 2012 Jun;12(12):2045-59. doi: 10.1002/pmic.201100370. Proteomics. 2012. PMID: 22623141

8

Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.

Gemei M, Corbo C, D'Alessio F, Di Noto R, Vento R, Del Vecchio L. Gemei M, et al. Proteomics. 2013 Nov;13(22):3293-7. doi: 10.1002/pmic.201300170. Epub 2013 Oct 9. Proteomics. 2013. PMID: 24106197

9

Cytometric profiling of CD133+ cells in human colon  carcinoma cell lines identifies a common core phenotype  and cell type-specific mosaics.

Gemei M, Di Noto R, Mirabelli P, Del Vecchio L. Gemei M, et al. Int J Biol Markers. 2013 Sep 27;28(3):267-73. doi: 10.5301/JBM.5000020. Int J Biol Markers. 2013. PMID: 23709346 Free article.

10

The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection.

Mariotti E, Gemei M, Mirabelli P, D'Alessio F, Di Noto R, Fortunato G, Del Vecchio L. Mariotti E, et al. Among authors: gemei m. BMC Cancer. 2010 Mar 30;10:120. doi: 10.1186/1471-2407-10-120. BMC Cancer. 2010. PMID: 20353562 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page